These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3192049)

  • 1. [Effect of blood components in hemotherapy on the factors of anti-infectious protection in patients with acute leukemias].
    Martynova VA; Abakumov EM; Ermakova GL; Pobedinskaia IN
    Gematol Transfuziol; 1988 Aug; 33(8):16-9. PubMed ID: 3192049
    [No Abstract]   [Full Text] [Related]  

  • 2. Alloimmunization by leukocyte-rich or leukocyte-poor random single donor platelets.
    Gmür J; Burger J; Sauter C; Oelz O; Frick PG
    Prog Clin Biol Res; 1990; 337():45-8. PubMed ID: 2191337
    [No Abstract]   [Full Text] [Related]  

  • 3. [Targetted hemotherapy with special reference to the cellular components].
    Dörner R
    Dtsch Med Wochenschr; 1990 Jul; 115(27):1066-72. PubMed ID: 2194776
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfusion therapy with platelets and leukocytes.
    Luban NL
    Pediatr Ann; 1983 Jun; 12(6):437-44. PubMed ID: 6348681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Formation of anti-leukocyte antibody and anti-platelet antibody and its effects on blood component transfusion].
    Shimoyama M; Minato K; Ideura Y; Kimura K
    Nihon Rinsho; 1977 Dec; 35(12):4146-54. PubMed ID: 342757
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood component therapy. Supportive therapy for acute leukemia (author's transl)].
    Maekawa I; Sakurada K; Shiraishi T
    Hokkaido Igaku Zasshi; 1977 Jul; 52(4):381-6. PubMed ID: 336501
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological support of component blood transfusion therapy].
    Shablin VN; Serova LD; Abdulkadyrov KM; Mel'nikova VN
    Probl Gematol Pereliv Krovi; 1978 Aug; 23(8):3-7. PubMed ID: 683985
    [No Abstract]   [Full Text] [Related]  

  • 8. [Refractory effect and alloimmunization after transfusion of thrombocytes].
    Volkova RI; Agranenko VA
    Gematol Transfuziol; 1992 Feb; 37(2):16-21. PubMed ID: 1426903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion of blood components and skin allograft survival in rabbits.
    Fagiolo U; Corsano A; Zanon GF; Zannini G; Sogaro F; Lise M
    Transplant Proc; 1979 Jun; 11(2):1446-7. PubMed ID: 382537
    [No Abstract]   [Full Text] [Related]  

  • 10. [The importance of leukocyte and thrombocyte concentrates in the treatment of acute leukemia].
    Fehérvízyová E; Hrubisko M; Danihelová E; Holománová D
    Vnitr Lek; 1986 Aug; 32(8):776-83. PubMed ID: 3765415
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood component therapy.
    Lister TA; Yankee RA
    Clin Haematol; 1978 Jun; 7(2):407-23. PubMed ID: 354836
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemotherapy in malignant hematologic diseases].
    Marti HR
    Schweiz Med Wochenschr; 1975 Jun; 105(24):778-9. PubMed ID: 49923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of platelet-transfusion therapy administered to patients with acute leukemia.
    Kutti J; Zaroulis CG; Dinsmore RE; Reich L; Clarkson BD; Good RA
    Transfusion; 1982; 22(1):44-7. PubMed ID: 7064206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various indices of natural immunity after transfusion of packed leukocytes into hemoblastosis patients].
    Faĭnshteĭn FE; Martynova VA; Ermolovich SV; Khoroshko ND
    Gematol Transfuziol; 1984 Sep; 29(9):13-6. PubMed ID: 6519425
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transfusion of leukocytes and platelets in the treatment of acute leukemia].
    Baklaja R; Stajić M; Banicević B; Jancić M; Cvetković V; Maslovarić S; Susaković N; Andelić M; Stefanović S
    Bilt Hematol Transfuz; 1978; 6(3):31-8. PubMed ID: 295220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune thrombocytopenia associated with acute nonlymphocytic leukemia.
    Amylon MD; Link MP; Glader BE
    J Pediatr; 1984 Nov; 105(5):776-8. PubMed ID: 6502309
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in non-MHC restricted cytotoxic activities of human peripheral blood lymphocytes after transfusion with allogeneic leukocytes or platelets possessing class I and/or class II MHC molecules.
    Pócsik E; Mihalik R; Réti M; Gyódi E; Pálóczi K; Mayer K; Kassai M; Herold M; Huber C; Petrányi GG
    Immunobiology; 1990 Dec; 182(1):22-31. PubMed ID: 1983002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of acute leukemias by auto-transfusion of x-irradiated blood].
    CROIZAT P; REVOL L; PAPILLON J; PINET ; BUSSY
    Lyon Med; 1951 Oct; 185(42):271-4. PubMed ID: 14889974
    [No Abstract]   [Full Text] [Related]  

  • 19. An enzyme linked immunosorbent assay for leucocyte and platelet antibodies.
    Doughty R; James V; Magee J
    J Immunol Methods; 1981; 47(2):161-9. PubMed ID: 7320510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusion therapy and circulating immune complexes.
    Safai-Kutti S; Zaroulis CG; Day NK; Good RA; Kutti J
    Vox Sang; 1980 Jul; 39(1):22-7. PubMed ID: 7445473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.